Lavipharm S.A Cash Flow-to-Debt Ratio
Lavipharm S.A cash flow-to-debt ratio. Lavipharm S.A (LAVI) has a Cash Flow-to-Debt Ratio of 0.01x as of December 2022, meaning its operating cash flow of €527.00K could theoretically repay 0% of its total liabilities (€73.89 Million) in one year. Check Lavipharm S.A cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Lavipharm S.A (2014–2024)
Cash flow-to-debt ratio of Lavipharm S.A from 2014 to 2024. Historical debt coverage capacity for Lavipharm S.A across 11 annual periods. Check LAVI cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Lavipharm S.A Cash Flow-to-Debt Ratio by Year (2014–2024)
Lavipharm S.A cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for Lavipharm S.A. For the full cash flow conversion analysis, see Lavipharm S.A cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.06x | €4.64 Million | €72.52 Million | ▲ +1522.5% |
| 2023 | 0.00x | €284.00K | €72.02 Million | ▼ -91.3% |
| 2022 | 0.05x | €3.35 Million | €73.89 Million | ▼ -25.7% |
| 2021 | 0.06x | €3.82 Million | €62.68 Million | ▲ +34.6% |
| 2020 | 0.05x | €2.85 Million | €62.94 Million | ▼ -0.1% |
| 2019 | 0.05x | €2.89 Million | €63.82 Million | ▲ +96.5% |
| 2018 | 0.02x | €1.42 Million | €61.43 Million | ▼ -1.4% |
| 2017 | 0.02x | €1.51 Million | €64.73 Million | ▲ +208.8% |
| 2016 | 0.01x | €606.00K | €80.00 Million | ▲ +93.1% |
| 2015 | 0.00x | €576.00K | €146.80 Million | ▼ -78.1% |
| 2014 | 0.02x | €2.38 Million | €132.79 Million | — |